Completed

NCT Number: NCT01642992

Korean Coronary Bifurcation Stenting (COBIS) Registry II

The COBIS II registry is a multi-center, real-world registry of drug-eluting stenting in coronary bifurcation lesions in South Korea. From 18 major coronary intervention centers in Korea, a total of 2,873 patients were enrolled in this database between January 2003 and December 2009.

The aim of the study was to investigate long-term clinical results and predictors of adverse outcomes after percutaneous coronary intervention with drug-eluting stents for coronary bifurcation lesions in South Korea.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronary Bifurcation Lesion

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Samsung Medical Center

Seoul, 135-710, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age >= 18 years
Any type of bifurcation lesion in major epicardial artery
Side branch reference diameter >= 2.3 mm and at least stentable with 2.5 mm stent
Treated with drug-eluting stent

Exclusion criteria

Protected left main disease previous CABG for LAD or LCX territory
Cardiogenic Shock
History of CPR in the same hospitalization

Treatment and study plan

Primary outcomes

Incidence of the composite outcomes of cardiac death, target vessel-related myocardial infarction, or target-lesion revascularization

Time frame: 3 years

Secondary outcomes

Cardiac death

Time frame: 3 years
Myocardial infarction

Time frame: 3 years
Target lesion revascularization

Time frame: 3 years
Stent thrombosis

Time frame: 3 years

Sponsors and collaborators

Lead sponsor

Hyeon-Cheol Gwon

Other

Registry information

Important dates

Study start: 2011
Primary completion: 2012
Study completion: 2012
First posted: Jul 17, 2012
Registry last updated: Jan 10, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed